#ANNA26 To view or add a comment, sign in Mesutoclax (ICP-248) is a next-generation, orally active, selective BCL-2 inhibitor designed to restore apoptosis in malignant cells dependent on BCL-2 overexpression
this combination has been shown to decrease appetite, blood glucose, and hunger in the hours following a meal with 2-3 eggs
NEW YORK August 4, 2025 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
It targets key regulatory pathways including incretin signalling, adipokine regulation, and lipid metabolism, and is studied as a tool for multi-pathway metabolic research in preclinical models
By encasing the glutathione in a phospholipid shell, it protects the molecule from being destroyed by stomach acid
